Insider · CIK 0001765987

Ostertag Eric

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001765987

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-01	Poseida Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−11.8K sh	$7.00	−$82.4K	827,320
2022-08-08	Poseida Therapeutics, Inc.P Purchase	Director	PPurchase	+143K sh	$3.50	+$500K	838,824
2022-08-03	Poseida Therapeutics, Inc.S Sale	Director	SSale	−161K sh	$3.69	−$593K	0
2022-02-01	Poseida Therapeutics, Inc.A Award	Director	AAward	+89.5K sh	—	—	692,967
2022-02-01	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director	AAward	+119K sh	—	—	118,708
2022-02-01	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,792
2021-12-30	Poseida Therapeutics, Inc.G Gift	Director	GGift	−94K sh	—	—	603,467
2021-12-30	Poseida Therapeutics, Inc.G Gift	Director	GGift	−48.9K sh	—	—	580,292
2021-11-19	Poseida Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,000 sh	$9.15	+$9,150	697,422
2021-11-19	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,000 sh	—	—	739,995
2021-11-08	Poseida Therapeutics, Inc.S Sale	Director	SSale	−9,873 sh	$7.09	−$70K	3,659,503
2021-11-08	Poseida Therapeutics, Inc.S Sale	Director	SSale	−9,051 sh	$7.09	−$64.2K	3,358,455
2021-10-11	Poseida Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.5K sh	$9.15	+$170K	696,422
2021-10-11	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.5K sh	—	—	740,995
2021-10-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−10.5K sh	$7.02	−$73.4K	3,669,376
2021-10-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−9,579 sh	$7.02	−$67.2K	3,367,506
2021-09-20	Poseida Therapeutics, Inc.S Sale	Director	SSale	−20K sh	$8.00	−$160K	160,696
2021-09-14	Poseida Therapeutics, Inc.S Sale	Director	SSale	−20K sh	$8.14	−$163K	180,696
2021-09-13	Poseida Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,757 sh	$1.17	+$3,233.961	656,891
2021-09-13	Poseida Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.5K sh	$9.15	+$169K	675,415
2021-09-13	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,757 sh	—	—	0
2021-09-13	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.5K sh	—	—	759,520
2021-09-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−32K sh	$8.34	−$267K	3,679,826
2021-09-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−29.3K sh	$8.34	−$244K	3,377,085
2021-09-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−26.7K sh	$8.46	−$226K	3,711,789
2021-09-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−24.5K sh	$8.46	−$207K	3,406,384
2021-08-06	Poseida Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+111K sh	$9.15	+$1.02M	654,134
2021-08-06	Poseida Therapeutics, Inc.Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−111K sh	—	—	778,044
2021-08-03	Poseida Therapeutics, Inc.S Sale	Director	SSale	−10.4K sh	$7.99	−$83.1K	3,738,475
2021-08-03	Poseida Therapeutics, Inc.S Sale	Director	SSale	−9,535 sh	$7.99	−$76.2K	3,430,847
2021-08-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−7,167 sh	$8.13	−$58.3K	3,748,876
2021-08-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−6,570 sh	$8.13	−$53.4K	3,440,382
2021-07-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−104 sh	$9.65	−$1,003.6	3,770,309
2021-07-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−14.3K sh	$8.90	−$127K	3,756,043
2021-07-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−96 sh	$9.65	−$926.4	3,460,028
2021-07-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−13.1K sh	$8.90	−$116K	3,446,952
2021-07-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−10.7K sh	$9.77	−$105K	3,770,413
2021-07-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−9,834 sh	$9.77	−$96.1K	3,460,124
2021-06-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−21.2K sh	$8.34	−$177K	3,781,142
2021-06-02	Poseida Therapeutics, Inc.S Sale	Director	SSale	−19.5K sh	$8.34	−$162K	3,469,958
2021-06-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−21.5K sh	$8.61	−$185K	3,802,388
2021-06-01	Poseida Therapeutics, Inc.S Sale	Director	SSale	−19.7K sh	$8.61	−$170K	3,489,434
2021-05-04	Poseida Therapeutics, Inc.S Sale	Director	SSale	−18.8K sh	$8.44	−$158K	3,823,881
2021-05-04	Poseida Therapeutics, Inc.S Sale	Director	SSale	−17.2K sh	$8.44	−$145K	3,509,135
2021-05-03	Poseida Therapeutics, Inc.S Sale	Director	SSale	−9,561 sh	$9.01	−$86.1K	3,842,656
2021-05-03	Poseida Therapeutics, Inc.S Sale	Director	SSale	−8,765 sh	$9.01	−$79K	3,526,346
2021-04-05	Poseida Therapeutics, Inc.S Sale	Director	SSale	−28.5K sh	$9.63	−$275K	3,853,834
2021-04-05	Poseida Therapeutics, Inc.S Sale	Director	SSale	−1,617 sh	$10.32	−$16.7K	3,852,217
2021-04-05	Poseida Therapeutics, Inc.S Sale	Director	SSale	−26.2K sh	$9.63	−$252K	3,534,107
2021-04-05	Poseida Therapeutics, Inc.S Sale	Director	SSale	−1,483 sh	$10.32	−$15.3K	3,532,624

Recent filings

Accepted (ET)
Feb 34
Ostertag Eric0001209191-23-006828
SEC(opens sec.gov)
Aug 104
Ostertag Eric0001209191-22-045296
SEC(opens sec.gov)
Aug 54
Ostertag Eric0001209191-22-044562
SEC(opens sec.gov)
Feb 14
Ostertag Eric0001209191-22-006170
SEC(opens sec.gov)
Nov 224
Ostertag Eric0001209191-21-066229
SEC(opens sec.gov)
Nov 104
Ostertag Eric0001209191-21-063934
SEC(opens sec.gov)
Oct 134
Ostertag Eric0001209191-21-060403
SEC(opens sec.gov)
Oct 54
Ostertag Eric0001209191-21-059651
SEC(opens sec.gov)
Sep 224
Ostertag Eric0001209191-21-057289
SEC(opens sec.gov)
Sep 154
Ostertag Eric0001209191-21-056246
SEC(opens sec.gov)

Companies

Poseida Therapeutics, Inc.Director

Address

C/O POSEIDA THERAPEUTICS, INC. 9390 TOWNE CENTRE DRIVE, STE 200

SAN DIEGO, CA, 92121